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ABSTRACT
Transplantedmultipotent human fetal neural stem cells (hfNSCs) significantly improved the function
of parkinsonian monkeys in a prior study primarily by neuroprotection, with only 3%–5% of cells
expressing a dopamine (DA) phenotype. In this paper, we sought to determine whether further ma-
nipulation of the neuralmicroenvironment by overexpression of a developmentally criticalmolecule,
glial cell-derived neurotrophic factor (GDNF), in the host striatum could enhanceDAdifferentiation of
hfNSCs injected into the substantia nigra and elicit growth of their axons to the GDNF-expressing tar-
get. hfNSCswere transplanted into themidbrain of 10 greenmonkeys exposed to 1-methyl-4-phenyl-
1,2,3,6-tetrahydro-pyridine. GDNF was delivered concomitantly to the striatum via an adeno-
associated virus serotype 5 vector, and the fate of grafted cells was assessed after 11 months. Donor
cells remained predominantly within the midbrain at the injection site and sprouted numerous
neurofilament-immunoreactive fibers that appeared to course rostrally toward the striatum in par-
allel with tyrosine hydroxylase-immunoreactive fibers from the host substantia nigra but did notma-
ture into DA neurons. This work suggests that hfNSCs can generate neurons that project long fibers in
the adult primate brain. However, in the absence of region-specific signals and despite GDNF over-
expression, hfNSCs did not differentiate into mature DA neurons in large numbers. It is encouraging,
however, that theadult primatebrainappeared to retain axonal guidance cues.Webelieve that trans-
plantation of stem cells, specifically instructed ex vivo to yield DA neurons, could lead to reconstruc-
tion of some portion of the nigrostriatal pathway and prove beneficial for the parkinsonian
condition. STEM CELLS TRANSLATIONAL MEDICINE 2014;3:692–701
INTRODUCTION
Human stem/precursor cells from multiple sour-
ces arebelieved tohold regenerative potential for
many disorders. Studies have shown the func-
tional benefit of cell-based therapies for diseases
of the central nervous system (CNS), including
Parkinson’s disease (PD) [1] and others. Numer-
ous studies in rodents and nonhuman primates
have shown that grafts of fetal dopamine (DA)
neurons can lead to behavioral improvements
[2–5] due to replacement of depleted transmit-
ters or neuronal protection. However, translating
these improvements to PDpatients has been vari-
able [6–8].
Glial cell-derived neurotrophic factor (GDNF)
is essential for nervous systemdevelopment, spe-
cifically, for the survival of ventral mesencephalic
(VM) DA neurons in vivo [9, 10], and acts as a che-
moattractant for stem cells in the brain [11]. Al-
though exogenous GDNF delivered by a variety
of approaches (including pump, cell secretion,
and viral vectors) has been of equivocal benefit
in clinical studies, its action on VM cells remains
undisputed [12–15].
Until recently [16, 17], attempts to establish
new anatomically appropriate nigrostriatal (NS)
axonal projections from fetal DA neurons placed
within the ventral mesencephalon had been met
withmodest success [18, 19]. However, we found
that exogenous expression of GDNF transduced
by adeno-associated virus (AAV) in the host stria-
tum overcame what was suspected to be a non-
permissive growth environment, increased the
survival of ectopically placed fetal VM grafts by
several fold, elicited highly directional axonal
outgrowth [20], and improved parkinsonism
alone or in combination with fetal VM grafts [21].
Moreover, VM grafts in the substantia nigra (SN)
projected tyrosine hydroxylase-immunoreactive
(TH-ir) fibers across substantial distances to
the host striatum when exposed to exogenous
vector-delivered GDNF [17]. Others have shown
in rodent models that primary DA neuroblasts
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FETAL AND NEONATAL STEM CELLS
implanted into the SN regenerated neurites that aligned with
the NS pathway [16]. This target-directed growthwas enhanced
further by striatal GDNF overexpression and supported the ra-
tionale for a dual therapeutic approach of cell transplantation
with neurotrophic factor delivery to achieve NS reconstruction
in animal models of PD.
Previously, we demonstrated that primary, forebrain human
fetal neural stem cells (hfNSCs) derived from the ventricular zone
(VZ) can engraft, migrate, and promote significant functional
improvements when transplanted into severely parkinsonian
monkeys, which are excellent models of PD [22–24]. Histological
analysis revealed that 3%–5% of the donor-derived cells
expressed TH, which suggests that themechanism of therapeutic
action was secondary support from donor cells on host DA neu-
rons including normalization of endogenous TH-ir cell numbers,
size, and function while preserving connectivity and diminishing
a-synuclein aggregates. Consequently, we hypothesized that in-
creasing signals in the environment through GDNF overexpression
could increase the proportion of donor-derived DA neurons that
spontaneously emerge from undifferentiated hfNSCs.
Studies utilizing immature primary fetal VM DA neuroblasts,
neural progenitor cells, or early postmitotic neurons transplanted
into other adult CNS locations, homotopic and heterotopic, dem-
onstrated the capacity to extend target-specific neurites over
relatively long distances [25–30]. Given strong evidence for a per-
missive NS growth environment for newly generated neuritic
processes in rodents [16, 26, 27] and primates [17], it is feasible
that hfNSCs also might respond to similar trophic stimuli in vivo.
Immature fetal VMDAneuroblasts and other postmitotic VM cell
types respond to environmental stimuli and develop into mature
midbrainA9DAneurons in vitro [31] and in vivo [28, 29, 32].GDNF
is a logical candidate for testing whether environmental alter-
ation can inducehfNSCs tomature further and ingreater numbers
into midbrain DA neurons and innervate appropriate target
regions in the DA-depleted primate brain.
We tested whether overexpression of GDNF transduced by
AAV serotype 5 (AAV5-GDNF) and injected into the dopamine-
depleted primate striatum could enhance graft integration and
improve DA differentiation of multipotent donor hfNSCs injected
at the same time into the SN as well as elicit directional neuritic
outgrowth from the SN to the appropriate target (i.e., the
striatum).
MATERIALS AND METHODS
hfNSCs were derived from the forebrain VZ and infected with an
enhanced green fluorescent protein (eGFP) lentivirus, as de-
scribed previously [33–35]. Subpopulations of hfNSCs were then
extensively characterized in vitro for known neural developmen-
tal markers by immunohistochemistry, Western blot, and quanti-
tative polymerase chain reaction to confirm neural stem cell
(NSC) lineage. Ten adult St. Kitts green monkeys were exposed
to 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP; Sigma-
Aldrich, Allentown, PA, http://www.sigmaaldrich.com) to induce
moderate dopaminergic deficits and were randomized for treat-
ment [36]. hfNSCs labeled with 5-bromo-29-deoxyuridine (BrdU)
andeGFPwere unilaterally grafted into themidbrain [23], followed
by unilateral AAV-GDNF injection into the ipsilateral striatum of
each monkey [17]. Two animals were sacrificed after 1.5 months
to confirm graft survival. The remaining eight monkeys were
injected with the retrograde tracer FluoroGold (Fluorochrome,
LLC, Denver, CO, http://www.fluorochrome.com) [17] and sacri-
ficed at 11 months after transplantation. Following sacrifice,
grafted hfNSCs and endogenous dopaminergic circuitry were
assessedhistologically for neural lineagemarkers aswell as immu-
nological rejection and overt pathology. Detailedmethodology for
all experiments can be found in the supplemental online data.
RESULTS
hfNSCs Grafted Into the Midbrain With Overexpression
of GDNF in the Striatum
To determine whether undifferentiated hfNSCs can further
differentiate and respond to GDNF chemotaxis in vivo, 10
MPTP-lesioned adult monkeys received injections of AAV5-
GDNF unilaterally into both the rostral caudate and postcom-
missural putamen, followed by a unilateral graft of eGFP- and
BrdU-labeled hfNSCs to the ipsilateral SN (supplemental online
Table 1). Animals were sacrificed at 1.5 months or 11 months
andwere analyzed forGDNF expression and derivatives of the do-
nor hfNSCs. Extensive in vitro characterizationof undifferentiated
hfNSCswasperformedprior totransplantationtoensureuniformity
andmaintenance of the NSC phenotype (supplemental online Figs.
1–4, supplemental online Table 2, and supplemental online data).
AAV5-GDNF Distribution
Extensive unilateral expression of AAV5-GDNF at 1.5 months
(supplemental online Fig. 5) and long term at 11 months (Fig.
1) was confirmed in the injected striatum, extending outward
from the injection sites throughout the caudatenucleus andputa-
men. GDNF-immunoreactive (GDNF-ir) cells were distributed
from the most dorsal-rostral regions of the lateral extent of the
striatum, extending ventrally through the caudate nucleus and in-
to the most caudal regions of the putamen. Transduced host
GDNF-ir striatal cells were predominantly neuronal nuclei-
immunoreactive (datanot shown)andhad thecharacteristicmor-
phology of medium spiny neurons (Fig. 1). A small percentage of
GDNF and glial fibrillary acidic protein-immunoreactive (GFAP-ir)
astrocytes were found in the most dorsal-rostral regions of the
lateral extent of the caudate (data not shown). GDNF also was
abundant in theSN, ipsilateral to the injected striatum (Fig. 1). Do-
paminergic neuronal somata and their processes in the SN were
densely GDNF-ir, suggesting either retrograde transport from DA
terminals or anterograde transport along the NS pathway to rel-
evant targets including the globus pallidus and SN. In addition,
exogenous AAV5-GDNF was not seen in the contralateral hemi-
sphere, indicating lateralized delivery (Fig. 1).
Endogenous TH-ir Cells Within the Nigrostriatum
Analysis of TH-ir cell bodies locatedwithin the SNand their axonal
projections to the striatum revealed, as per our prior studies [37,
38], ∼50% reduction in the number of endogenous TH-ir cells
(characteristic of an asymptomaticMPTP-lesionedmonkey) com-
pared with control animals. Asymptomatic MPTP-lesioned mon-
keys were used because they had the biological effects of DA
depletion but were able to care for themselves. At 11 months af-
ter transplantation, a moderate level of host TH-ir NS fibers were
present, suggesting that theywere sparedor rescued fromdegen-
eration (Fig. 2). In addition, host TH-ir fibers appeared to fill the
interstitial spaces with extensively arborized neuritic processes.
Host fiber outgrowth was likely a result of GDNF neurotrophic
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support within the SN and possibly also from hfNSC graft-derived
factors.
HfNSC Graft Distribution and Morphology
In order to assess graft survival and distribution, we analyzed
brains for markers of transplanted cells. Robust grafts of
donor-derived cells typically were located in the most dorsal-
rostral region of the host SN. After 1.5 months, donor cells
remained within the target site and did not migrate to the hemi-
sphere contralateral from the injection site (supplemental online
Fig. 6). Grafted BrdU-immunoreactive cells were clustered within
and immediately adjacent to the TH-ir dense regions of the SN,
juxtaposed to endogenous TH-ir processes (supplemental
online Video 1). Donor cells retained an undifferentiated mor-
phology, typicallywith little ornoarborization. By11monthsafter
transplantation, dense GFP-immunoreactive (GFP-ir) grafts were
found at the dorsal region of the SN, with extensive processes in
fourof fiveanimals. Hemisphereswereanalyzed volumetrically to
determine overall graft density (supplemental online Table 3).
One animal that did not show markers for graft survival and
the twoanimals transplantedwith cells killed ex vivo (control) dis-
played neither aberrant host pathology in the SN nor apparent
long-term injury from the transplantation procedure. In addition,
GFP-ir cells remained in the needle tract in three of four animals,
where many dorsally oriented GFP-ir cells displayed a highly
branched stellate morphology, consistent with astroglia, al-
though the majority lacked GFAP-ir. Larger grafts (Fig. 2) dis-
played a distribution pattern and fibers reminiscent of grafts
previously reportedusing primary human fetal DAmesencephalic
neuroblasts implanted into the rostral mesencephalon or inter-
nal capsule [29] but lacked long (.3 mm) neuritic projections
extending toward striatal target regions.
Characterization of Neurite Outgrowth
Given the robust survival of transplanted cells, we next analyzed
fiber outgrowth. Donor GFP-ir cells displayed a soma located
within the core of the graft and one process or more extending
.1 mm into host tissue from the periphery of the graft. Fibers
coursed inmultiple trajectories out of the graft zone.When grafts
overlappedwith anatomical regions containing endogenous fiber
tracts, the direction of neurite outgrowth was often parallel to
these fibers. GFP-ir cells located at the dorsal-rostral region of
the graft had projectionsmore rostrally through the zona incerta,
ascending past the subthalamic nuclei toward the internal cap-
sule and fields of Forel. Caudal fibers generally remained within
the graft zone or projected ventrally into the SN and further to-
ward the cerebral peduncle of the mesencephalon and medial
lemniscus of the pons andmedulla. GFP-ir fibers also coursed ad-
jacent to or through endogenouswhitematter tracts. In addition,
longprotrudingGFP-ir fibers coursed through the SNand the nee-
dle tract. When grafts overlapped the NS pathway, fibers ex-
tended rostrally with a trajectory that paralleled TH-ir fibers of
the host NS pathway (Fig. 2). These fibers accounted for only
4%–7% of the total fiber outgrowth from the entire graft, indicat-
ing that the directional preferencewas due to graft position along
an existing endogenous fiber tract rather than inherent direc-
tional preference toward the striatal target. GFP-ir processes lo-
cated at the dorsal-rostral region of the graft, in addition to those
locatedwhere the needle tract overlappedwith the NS tract, often
terminated in bifurcated end-feet, morphologically resembling
growth cones. Throughout the graft, intricate rostrocaudal
branching of thin GFP-ir fibers could be seen at the ends of
thick axons, with highly ramified terminals located both short
and long distances from the transplantation zone. These
results demonstrate robust survival and extensive fiber out-
growth from donor cells.
Graft Lineage Specification
In order to determine the lineage fate of hfNSCs, we analyzed
grafts by immunohistochemistry for expression of neural
lineage-specific markers. After 11 months, 12%–17% of grafted
GFP-ir fibers colocalized with nestin (supplemental online Fig. 7)
Figure 1. Exogenous adeno-associated virus serotype 5-GDNF expression after 11 months. Adeno-associated virus serotype 5-GDNF was
expressed throughout the STR (A, C, G, H), emanating from the injection sites into adjacent tissue. (B): Exogenous GDNF was not found in
the contralateral hemisphere; however, GDNF-immunoreactive cell bodies and fibers were also seenwithin the ipsilateral SN (D, F), suggesting
retrograde transport from the striatal injection sites. Most GDNF-transduced cells had the characteristic morphology of medium spiny projec-
tion neurons throughout the striatum (G) as well as astrocytes in some regions of the caudate (H). (E): Robust GDNF-immunoreactive cells were
also found near the locus ceruleus. Scale bars = 2mm (A, B), 50mm (C), 500mm (D), 100mm (E, F), and 10mm (G, H). Abbreviations: GDNF, glial
cell-derived neurotrophic factor; SN, substantia nigra; STR, striatum.
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and 3%–9% with vimentin (data not shown), both intermediate
filaments associated with undifferentiated NSCs. Overall,
67%–87% of GFP-ir cells colocalized with neurofilament (NFM)
(Fig. 3) but did not express significant levels of the more mature
neuronal proteinmicrotubule-associated protein 2 (MAP2), asso-
ciatedwith dendrites (∼1%ofGFP-ir/NFM-immunoreactive cells)
(supplemental online Fig. 7). In addition, few (0.1%–1.1%) donor-
derived GFP-ir cells coexpressed the dopaminergic enzyme TH
(Fig. 4). Some GFP-ir/TH-ir cells developed larger soma but with-
out marked arborization of processes in distinction to mature
midbrain DA neurons. Of note, few grafted cells expressed GFAP,
even in astrocyte-rich regions of the brain, or Tuj1/bIII-tubulin,
a marker of immature neurons (supplemental online Fig. 7).
Many longer (.800 mm) GFP-ir fibers exhibited morpholog-
ical features of a variety of mature, monoamine neuronal pheno-
types. Very fine, densely packed, small (0.3–0.06 mm) beaded
varicose GFP-ir fibers, characteristic of DA neuron terminals
[39], were found as diffuse spottedmasseswithin the SN and pro-
truding from the dorsal-rostral region of the graft (Fig. 5). In ad-
dition, GFP-ir cells contained both thick and thin smoothprocesses
similar to nonterminal ends of monoamine axons as well as both
small and large beaded processes typical of catecholaminergic
and serotonergic neurons [40–42]. Numerous processes of differ-
ing thickness had abundant round or fusiform enlargements
(i.e., “varicosities”) spaced at variable distances and number
per unit length. Furthermore, many longer processes terminated
in highly branched, “spine-like” structures (Fig. 5). These results
indicate that although grafted hfNSCs differentiate into neuronal
phenotypeswithmorphologicallymature fibers, they fail to prop-
erly differentiate into biochemically relevant DA neurons.
FluoroGold Tract Tracing
To determine whether GFP-ir neuritic processes innervated stria-
tal targets, we analyzed retrograde transport from striatal termi-
nals to the SN using FluoroGold. Densely labeled FluoroGold-
immunoreactive (FluoroGold-ir) endogenous cells were found
throughout the injected striatum (supplemental online Fig. 5).
Some endogenous nigral TH-ir cell bodies were FluoroGold-ir,
demonstrating retrograde transfer to the SN. No GFP-ir/
FluoroGold-ir donor cells were found in the SN, suggesting a lack
of striatal innervation from cells injected near the SN after 11
months in vivo. In addition, GFP-ir processes were not found near
themost caudal regions of the striatum,whereDAaxons from the
Figure 2. Long-term engraftment of GFP-immunoreactive (GFP-ir) donor cells at 11 months after transplantation. After 11 months, robust
GFP-ir donor-derived grafts (A–D)were found to project extensive fibritic output into the peripheral tissue, including SN, as indicated by TH-
immunoreactive dopamine cells (C). Another GFP-ir graft was located in an equivalent location (D), and two other grafts were located at the
most dorsol-rostral extent of the SN (data not shown). (A, C, D): Cells were also found filling the injection cavity created from needle in-
sertion-extraction in three of four animals successfully transplanted with GFP-ir cells. (A–D): Migration of cell bodies from the graft into
peripheral regions was never seen, including into the contralateral hemisphere. (E–G): Regions in which grafted cells overlapped with host
fiber tracts displayed a preference for growth parallel to endogenous fiber networks. Donor-derived GFP-ir cells projected growth cone-like
processes (G) parallel to spared endogenous TH-ir nigrostriatal circuitry. Dashed arrows indicate direction of host dopamine axons along
the nigrostriatal pathway. Scale bars = 1 mm (A), 100 mm (B), 200 mm (C, D), 10 mm (D’, D”), 200 mm (E), 100 mm (F), and 50 mm (G). (F, G)
are higher magnification images of the histological section in (E). Abbreviations: GFP, green fluorescent protein; SN, substantia nigra; TH,
tyrosine hydroxylase.
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SN enter, despite some graft fibers growing along a trajectory
parallel to the existing NS pathway. These results further argue
against striatal innervation or NS reconstruction.
Safety Concerns and Immunological Response
In order to access safety concerns regarding the transplantation
of fetal CNS tissue, we analyzed brains for signs of aberrant pa-
thology and immune response. We found no histological evi-
dence for gross anatomical aberrations based on cresyl violet
or 49,6-diamidino-2-phenylindole staining (data not shown), in-
cluding no cell overgrowth, tumor formation, or deformation of
normal host structures. In addition, Ki-67andproliferating cell nu-
clear antigen immunostaining revealed no evidence of sustained
proliferation within grafts at 1.5 months or 11 months (data not
shown), suggesting that hfNSCs do not continue to replicate long
term. Furthermore, LN3 staining indicated no accumulation of
microglia around the grafted region at 11 months following
hfNSC transplantation or in the two animals that received
killed-cell control transplants (data not shown). Together, these
results suggest no major anatomical changes or inflammatory
reactions in animals with successful grafts, in an animal with an
unsuccessful graft (one of five animals), or in controls that emu-
late an unsuccessful graft (dead hfNSCs).
The behavior of all subjects was video monitored regularly
both prior to MPTP lesioning and throughout the entire experi-
mental timeline and was assessed by trained, blinded observers.
Although animals selected for this study were deemed behavior-
ally asymptomatic (although biochemically DA deficient) by both
Parkinson’s Factor (PARK) score and Healthy Behavior score
[43, 44], we continued to monitor for negative side effects. The
individual factors included in PARK score and Healthy Behavior
score are similar to those seen in Parkinson’s disease patients
and based off deviations from normal activities as defined in
the cited references. No animals displayed an increase in parkin-
sonian behaviors for the entire postsurgical intervention period
or showed fewer healthy behaviors. However, two animals trans-
planted with hfNSCs displayed improved scores for signs of
healthy behaviors that neared statistical significance. These ani-
mals also displayed themost extensive graft survival and neuritic
output, suggesting that these grafts may be functional. No ani-
mals displayed adverse behaviors, dyskinesias, or signs of dis-
tress. These data support the long-term safety of hfNSC grafts
in the primate brain.
DISCUSSION
We previously reported that primitive multipotent hfNSCs trans-
planted intoparkinsonianmonkeyswithout prior ex vivodifferen-
tiation significantly improved behavioral deficits. Functional
improvement was mediated by presumed neuroprotection of
the extant host DA pathway, with only ∼3%–5% of donor-
derived cells spontaneously expressing DA [23]. In this study,
we sought to determine whether overexpression of the develop-
mentally criticalmolecule GDNF could enhance dopaminergic dif-
ferentiation of hfNSCs and direct axonal outgrowth toward an
appropriate target.
hfNSCs were transplanted stereotaxically dorsal to the sub-
stantia nigra of MPTP-lesioned St. Kitts green monkeys. AAV5-
GDNF concomitantly was injected to the striatum, and the fate
of grafted cells was assessed after nearly 1 year. Robust graft sur-
vival and extensive fiber outgrowth was evident at 11 months af-
ter transplantation. Donor cells generated neurons projecting
neurites parallel to DA fibers of the ascending, host NS tract
but did not mature into midbrain DA neurons based on environ-
mental cues alone, even after nearly a year. Encouragingly, the
adult primate brain appears to maintain an environment permis-
sive of integration and to retain axonal guidance cues. Conse-
quently, transplantation of alternative stem cell sources
instructed ex vivo to yield A9 midbrain lineage DA neurons may
hold considerable promise for neural repair.
Implications for PD Therapy
As noted above, in a series of our own studies, we demonstrated
that hfNSCs, derived from the forebrain VZ, retain the capacity to
engraft in the adult primate CNS, to migrate to disease loci, and
to promote functional improvements in parkinsonian monkeys
[22–24]. Similarly, others have shown lesion-induced migra-
tion [45, 46] and differentiation into NFM-70- and Map2-
immunoreactive neurons and GFAP-ir astrocytes, in addition to
extensive long-term axonal outgrowth [47–50] from undifferen-
tiated NSCs grafted into rodents. Moreover, when differentiated
Figure 3. Donor cell processes express NFM and pursue multiple
trajectories. (A–F): GFP-immunoreactive fibers colocalized with
NFM-immunoreactive fibers and exited via multiple directions into
host tissue. NFM-immunoreactive fibers were most abundant at
the distal tips of GFP-immunoreactive projections and became punc-
tate toward the soma. Scale bars =50mm (C) and20mm (F), and apply
to (A–C) and (D–F), respectively. Abbreviations: GFP, green fluores-
cent protein; NFM, neurofilament.
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in vitro [23, 51] or transplanted in 6-hydroxydopamine-lesioned
rats, cells with neuronal phenotype also expressed TH, albeit
sometimes transiently [47, 48, 50, 52], suggesting that hfNSCs re-
tain the plasticity to produce DA neurons; however, the mecha-
nism by which this was accomplished is not well-understood.
The stem cell field often has relied on regional cues alone, both
developmental and injury induced, to pattern the cell type fate
of undifferentiated NSCs [53–55]. Altering the extracellular ma-
trix [56] or exposing NSCs to astrocyte-derived factors [57]
seemed to augment that process, suggesting that such a strategy
alone might be effective. Even embryonic stem cells (ESCs)
appeared to yield functional DA neurons in a parkinsonian rat
modelwithout preinstruction [58]. Consequently, it remainedun-
clear to what extent undifferentiated, VZ-derived hfNSCs could
differentiate into mature, striatally integrated, midbrain DA neu-
rons based solely on environmental cues.
The evidence for some directional outgrowth of graft fibers
along trajectories parallel to endogenous host fiber tracts in this
study suggests that local axon guidance molecules persist and
may influence hfNSC neurite output in the DA-depleted primate
brain. Graft fibers displayed directional outgrowth only when
grafts directly overlapped with endogenous host circuitry, seem-
ingly taking advantage of pre-existing local guidance molecules.
Netrins, semaphorins, ephrins, and slits play critical roles during
thedevelopment ofmidbrainDAneurons [59, 60], but it is unclear
to what extent these guidance cues persist in the adult primate
brain and whether they retain instructive patterning cues during
degeneration. Our results not only help answer this question in
the affirmative but also suggest that the residual pathway may
facilitate NS reconstruction from homotopically placed grafts.
In this study, animals with partial lesions were chosen to allow
spared NS fibers to facilitate directional outgrowth through
the remaining NS pathway, as seen in experiments in the 6-
hydroxydopamine-lesioned mouse [16]. Fully lesioned animals
with little to no dopaminergic fibers remaining likely would
not retain the axonal guidance molecules or produce trophic
stimuli necessary for directed outgrowth. These data suggest
that if transplant-based therapies for PD were used, early
intervention—when some residual NS fibers are still present—
would be advisable.
In agreement with studies in cynomolgus monkeys [61],
AAV5-GDNF was efficient in transducing striatal projection neu-
rons, providing GDNF to surrounding tissue, and being trans-
ported to the SN. Consequently, donor and endogenous cells
were exposed simultaneously to GDNF at multiple levels: within
the SN, enhancing donor cell survival at the graft site, alongGFP-ir
fibers adjacent to GDNF-transduced striatonigral projections,
and locally within the striatal target to promote innervation.
Immunohistochemically, themajority of grafted cells appeared
to be transitioning from immatureNSCs tomoremature, highly ar-
borized neurons within the VM. Although many GFP-ir cells mor-
phologically resembled monoamine neuronal phenotypes, most
donor-derived cells lacked expressionof several characteristic neu-
ronal markers, including Tuj1 and MAP2 (isoforms a and b). Only
a few donor-derived GFP-ir cells possessed characteristics of DA
cells, including TH-ir soma, and of these, few had a size or axonal
profileconsistentwithmaturemidbrainA9DAneurons. Limited tis-
sue did not allow for characterization of specific mature neuronal
lineage subtypes such as A9 and A10 DA neurons or serotonergic,
noradrenergic, GABAergic, and glutamatergic neurons.
Given the substantial, nearly 1-year period of time between
transplantation and brain removal and the facilitated support
Figure 4. Fewdonor-derived cells express dopaminergicmarker TH. (A–I): SomeGFP-immunoreactive (GFP-ir) somawere also TH-immunoreactive
(TH-ir) in areas where grafted cells overlapped with spared endogenous TH-ir dopamine cells in the substantia nigra but typically lacked significant
arborization. (D–F) show higher magnifications of the box drawn in (C). (G–I) are from a differentmonkey than (A–F). Arrows point to GFP-ir donor-
derived TH-ir cells. Arrowheads point to endogenous TH-ir cells, and asterisks demarcate donor-derived GFP-ir cells that are not TH-ir. Scale bars =
200 mm (C) applies to (A–C), and 50 mm (F, I) applies to (D–I). Abbreviations: GFP, green fluorescent protein; TH, tyrosine hydroxylase.
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of exogenous GDNF along disease-relevant nigrostriatal tracts,
it is reasonable to suggest that transplanted VZ-derived hfNSCs
do not generate significant numbers of new mature midbrain-
specific DA neurons based on external niche-mediated cues
alone. AlthoughweusedhfNSCs, these results are consistentwith
a recent study demonstrating that adult NSCs lose their compe-
tency to generate region-specific neuronal populations early
during embryonic development and require Oct-4 induced re-
programming to efficiently differentiate into mature, functional,
midbrain-specific A9 DA neurons [62].
Surprisingly, few GFP-ir cells expressed the astrocytic marker
GFAP, although many had a morphology reminiscent of astro-
cytes. In previous studies in which hfNSCs were placed into the
striatum,we found that grafted cellsmigratedextensively anddif-
ferentiated into a small percentage of astrocytes [24]. In the pres-
ent study, hfNSCs were placed adjacent to the lesion zone (SN) of
partially lesioned primates, and we found no migration and very
little astrocytic differentiation. One possibility is that the striatal
environment maintains astrocytic differentiation cues, whereas
the VM appears to upregulate cues favoring neuronal differenti-
ation. These data suggest that the signaling cues at the transplan-
tation zone and in the lesion area may profoundly affect the fate
of grafted cells. In addition, degree of lesioning and persistence
of existing circuitry likely have a profound impact on donor cell
fate. Fully lesioned, severely parkinsonian animals have extensive
degeneration of both DA circuitry and a general breakdown of
the milieu, whereas asymptomatic animals retain enough DA
transmission to maintain healthy daily behaviors. Partial degen-
eration in asymptomatic animals may not require secondary glial
support or enact the same signaling mechanisms used by a fully
lesioned brain.
Safety considerations and immunological response to grafted
cells are important obstacles to consider for any cell-based ther-
apy. Host tissue within the transplantation zone displayed no
pathology, including no tumor formation, cell overgrowth, de-
formation of host cytoarchitecture, abnormal vascularization,
or inflammatory response that would suggest major immunol-
ogical rejection. In addition, graftedcellswerenegative formarkers
of ongoing proliferation, confirming previous findings that grafted
NSCs exit the cell cycle shortly after transplantation [50].
CONCLUSION
These results provide evidence that hfNSCs can engraft and sur-
vive long term in theMPTP-lesioned primate near the SNwhile its
striatal target is releasing an elevated concentration of GDNF.We
demonstrate, for the first time, morphologically relevant neuro-
nal differentiation from undifferentiated hfNSCs in the primate
DA-depleted midbrain with extensive fiber outgrowth, some of
which overlapped with host circuitry and coursed along trajecto-
ries congruent with the endogenous neural DA pathway. These
results suggest that grafted hfNSCs can develop and respond to
axonal guidance signaling molecules, confirming that the adult
Figure 5. Morphological characteristics of 11-month grafts suggest differentiation intomultiple neuronal phenotypes. (A–H):Histological en-
hancement of green fluorescent protein-immunoreactive (GFP-ir) fibers revealed extensive fibritic growth reminiscent of mature monoamine
neurons. FineGFP-ir fibers adornedwith varicosities (arrows) (B, F, H) projectedwithin the substantia nigra (A) andwere extremely dense at the
ventro-caudal and dorsal-rostral regionof the graft (B, C). SomeGFP-ir processeswere thicker and smooth (D) andmay reflect nonterminal ends
of axons, whereas other longer processes terminated in “spine-like” structures (arrowheads) (E, G). Scale bars = 250mm (A), 50mm (C, F, H), 25
mm (B, D, E), and 20 mm (G).
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brain retains permissive instructive cues for repair and recon-
struction [16, 26–29].
Previous investigators speculated that themicroenvironment
alone could direct the final phenotype of an immature cell. How-
ever, these results suggest that although the milieu can start the
process, it may not be sufficient to complete differentiation. Sim-
ply optimizing the environment via overexpressionofGDNF in the
milieu may have improved graft survival and rescue of endoge-
nous DA fibers, but it was not sufficient to direct differentiation
toward a VM phenotype or specify instruction to become mid-
brain dopamine neurons [63]. At the other end of the differ-
entiation spectrum, fate-committed DA neuroblasts readily
differentiate into TH-ir neurons and can efficiently reconstitute
new NS projections along existing host circuitry [16]. It is likely
that human ESC-derived and induced pluripotent stem cell-
derived DA precursors will also retain many of these valuable
characteristics. In fact, in vitro differentiation of human ESCs into
midbrain-specific, FoxA2-immunoreactive progenitors through
a floor plate (intermediate) has recently been shown as an effec-
tive strategy in both rodents and monkeys to overcome these
obstacles in experimental parkinsonism [63].
It is still unclear where along the broad continuum of DA neu-
ronal differentiation one should start for the safest and most ef-
fective replacement of A9 DA neurons in PD. An ideal approach
might be complete in vitro instruction toward the A9 DA lineage
with safeguards (e.g., positive selection for developmental genes
such as FoxA2, Lmx1a, and/orNurr1) that amass only cells in that
pathway andexclude others, such as thosewith oncogenic poten-
tial [58]. The approach of ensuring large populations of pure DA
neurons also demands knowledge of other aspects of PD that
might not be responsive to DA neuron replacement alone (e.g.,
neuroprotection, anti-inflammation, restoration of lysosomal and
proteosomal function, removingmisfolded proteins, replacing cor-
tical connections). Indeed,we should notminimize the importance
ofearly cell-mediated trophic supportandrestorationofspareden-
dogenous host neural circuitry, which may be critical for realizing
full functional improvement. Careful side-by-side comparison of
cell sourcesandrepair strategieswill berequiredtoderiveabroadly
applicable, safe, and effective cell-based treatment for PD.
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